Lynn Matrisian named chief research officer for the Pancreatic Cancer Action Network

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

LYNN MATRISIAN was named the inaugural chief research officer for the Pancreatic Cancer Action Network. Matrisian was promoted from vice president of scientific and medical affairs, where she has served since 2011. Doug Laidlaw was named vice president of scientific and medical affairs, and will be responsible for overseeing the nonprofit’s research grants, patient services...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Congress settled the FY26 question in February, with NCI receiving $7.352 billion, an increase of $128 million over the prior year. After a year in which cancer center directors spent an extraordinary share of their leadership attention defending the research enterprise, that outcome deserves to be called what it was: a win.
Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login